"We are seeking Environmental Protection Agency ("EPA") in the USA and Health Canada ("HC") approvals for all our intelligent fabric technologies and we look forward to market penetration if such certifications are received." stated Mr. Hylton Karon, President.
"With the expected increase in sales in the intimate apparel division starting in 2013 and the launch of intelligent fabrics to the North American market later this year the future looks promising for the Company" added Mr. Karon.
iFABRIC Corp., through its Intelligent Fabric Technologies North America Inc. (IFTNA) division, has exclusive global distribution and marketing rights for a new generation of intelligent textiles which have the ability to kill bacteria, repel insects and heal the skin amongst others. iFabric is also a a manufacturer, distributor, licensor and licensee of ladies intimate apparel products and accessories through its Coconut Grove division.
Infection control products market in the US in excess of US$15 billion by 2018;
Significant products sales opportunities based on its proprietary intelligent textile technologies;
Proven Protx2™ technology to combat wide variety of infectious diseases;
US EPA registration of Protx2™ completed, thus allowing US sales;
Pending US EPA approval of Enguard insect repellent fabric;
Fundamentally sound business model of its Coconut Grove apparel division
Intelligent Fabric Technologies North America Inc. (IFTNA)
In 2008, Intelligent Fabric Technologies (North America) Inc. began developing a wide range of products focused on the improved safety and well being of the wearer and user of fabrics across a wide range of market segments including medical, health care, sports and athletic, military, consumer and corporate apparel, bedding, linens and other market categories.|
The IFTNA division is currently focused on its regulatory, product development and marketing efforts on several key technologies, namely:
Protx2™ Anti Microbial Technology
The primary benefit of Protx2™ is itís unrivalled ability to control microbial growth (mold, mildew, fungi, bacteria, yeast, algae) by providing long-term effective control of micro-organisms on the product and thus promotes the effective life of the product. It is completely durable to wash and is not destroyed by repeated cleaning. Protx2™ís efficacy and safety has been documented in numerous peer reviewed publications, trade articles and certified tests.
The Protx2™ range of products is dedicated to combating hospital and community acquired infections including MRSA, VRE, and Klebsiella Pneumoniae; and by their application greatly assist in reducing the spread of such infections.
The Protx2™ cutting edge technology controls odour-causing bacteria, ensuring lasting freshness. It creates safe, effective and consistent protection against unpleasant odours. This multi-billion dollar market includes applications such as shoe insoles, sneakers and athletic shoes, hockey and other sports clothing and equipment.
Published estimates place the cost to the North American taxpayer of treating HAIís and deaths resulting from HAI's at
around US$33 billion annually. Other published estimates project that the US market for infection control products will
grow to in excess of US$15 billion by 2018.
US Federal EPA registrations in respect of Protx2™ (formerly Cliniweave and Cliniweave AV) were received in October 2012 and
December 2012 respectively and State registrations were completed in July 2013, thus allowing the Company to sell Protx2™ products throughout the US.
Learn more about Protx2™
- Enguard™ Mosquito Repellent Fabric
Applying Enguard to fabrics results in a highly effective and durable insect repellent. Fabrics treated with Enguard
require rubbing or scrunching in order to release the active ingredient. Once activated, Enguard protection lasts for
many hours. A major strength of Enguard is that it is safe for children. Testing carried out by the London School of
Hygiene and Tropical Medicine show Enguard to have repelling power comparable to high-concentration DEET and
significantly greater than any other natural insect repellents. The Enguard product lasts many months and can be
washed up to 10 times without losing effectiveness.
iFabric is in the process of securing approvals from the Environmental Protection Agency ("EPA") in the U.S.,
and Health Canada which will allow it to sell products utilizing the Enguard technology in North America with
appropriate claims. The receipt of such approvals are pending.
Learn more about Enguard
Dreamskin textile technology is safe for infants and helps encourage a healthy skin environment by its ability to either
increase or decrease moisture, a critical step in maintaining a healthy skin.
Dreamskin is effective during both summer and winter months as high and low moisture environments both offer
discomfort and irritation. In particular, athletic apparel has two key areas that can cause skin irritation, namely friction
and excessive moisture. Dreamskin targets both of these to help prevent irritation.
Applications include hosiery, infant apparel, athletic apparel, shape wear and intimate apparel amongst others.
Dreamskin treated fabrics have been approved by the Canadian Eczema Society.
RepelTX is a coating that is resistant to water and moisture and is environmentally friendly. The thin coating can be used on various surfaces including electronics and fabrics. They can now be protected against water and moisture by simply treating them in the fluorinated solvent. The coating dries in just over one minute at room temperature, and it starts working immediately once set.
RepelTX is the next generation in water repellency performance. RepelTX modifies fabric at the molecular level by permanently attaching hydrophobic Ďhairsí to individual fibers that lift liquids, causing them to bead and roll right off the fabric surface. It features a hydrocarbon polymer which is both more ecologically friendly and economically smart compared to competition. The result is excellent performance-liquid repellency thatís breathable, durable and fast drying.
FreshTx is a state of the art odour-absorbing technology, which is easily infused into textile products.
FreshTx offers permanent protection against odours without the need to use sprays or perfumes. FreshTx uses naturally-occurring elements for effective results that are non-toxic and safe. Extremely durable, once applied, FreshTx's properties are renewed with each wash, and is effective even when wet.
DryTx is an advanced moisture-wicking technology that quickly draws moisture away from the skin and disperses perspiration across the fabric allowing for faster evaporation, thereby improving the performance of the garment and allowing the wearer to maintain an even body temperature. The main attributes of DryTx is its ability to:
- Allow garments to wick moisture away from the skin
- Provide for garments that will not feel heavy or damp even during high exertion activities
- Reduce skin chafe as garments remain drier
- Allow garments to retain their natural softness
UVtx treatment provides apparel with a built-in UV blocker. Once applied, UVtx is extremely durable, providing for long-term UV protection equivalent to a sunblock strength of up to UPF30.
- temp+x with Friction Control
The built in technology temptx allows the fabric to react based on your current body tempurature helping regulate and keep your body in a comfortable state. The specially formulated polymer coates the fabric creating a smooth, surface to reduce chafing even in sensitive skin types
Coconut Grove division has, since 1985, manufactured, distributed and sold womenís intimate apparel and in particular a range of specialty bras including the Companyís patented backless, strapless underwire bra.
The Company also distributes a range of complimenting accessories. Coconut Groveís customer base includes a number of major retailers as well as specialty boutiques in Canada, the USA and UK..
In September, 2010, Coconut Grove signed its first exclusive worldwide license and distribution agreement with
Maidenform Brands, Inc. to manufacture and market products in its market segment under various
Maidenform brands. Maidenform is a global intimate apparel company with a portfolio of established, well-known
brands including Maidenform®, Control It!®, Fat Free Dressing®, Flexees®, Lilyette®,
Maidenformís Charmed®, Bodymates®, Inspirations®, Self Expressions® and Sweet Nothings®.
In January 2012 the Company signed a second license and distribution agreement with Mo Industries, LLC (a
subsidiary of VF Corporation) to manufacture and distribute intimate apparel under its Splendid and Ella Moss brands.
In terms of this agreement, licensed territories include Australia, Canada, China, the European Union, Mexico, the
Russian Federation, Singapore, the UAE, and the USA.
The Splendid® brand is known for its use of luxurious fabrics in a wide range of contemporary knit products
incorporating modern fit and styling. The Ella Moss® brand is an ultra-feminine collection of casual knit tops and
dresses featuring bold colors, whimsical styling and fashion silhouettes. Splendid® and Ella Moss® products are
currently marketed internationally, by a number of high-end retail and online chains, specialty boutiques as well as its
Hylton Karon - President, CEO and Director|
Hylton is a Graduate of Philadelphia University with a BSC degree in textile marketing and management. A member of the Groupís founding family, Hylton has over 30 years of experience in product development and marketing.
Hylton's creative ability has resulted in the development of many successful and patented products which are sold both in North America and Internationally. Hylton's leadership and motivational skills have been the main driving force for the Group's success to date.
Hilton Price - Chief Financial Officer and Director
Hilton is a Chartered Accountant with over thirty five years of experience covering a variety of industries and businesses. Hilton has been involved in most elements of the Group's strategic planning and has been responsible for financial oversight since the Group's inception.
Dr. Jeff Coyne - Chairman of the Board of Directors
Dr. Coyne is CEO of Provect Technologies, Inc., a U.S. based, enterprise level, time and attendance software company. He is a principal of CPR Turnaround LLC, a company that manages and advises companies in financial difficulty and he is a senior lecturing fellow at Duke University School of Law.
Dr. Coyne has previously served as a director of Ezenet (previously EZE on Toronto Stock Exchange) and ValueNet (previously VNE on the Exchange). His academic qualifications include BA, Economics, U.C. Berkeley; JK, Duke University School of Law. He is also a California licensed attorney.
Giancarlo Beevis - President and CEO, IFTNA
Giancarlo has been involved with the company for 10 years. He contributed expert knowledge to the company and is intrumental in the brand development of Intelligent Fabric Technologies North America. Today Giancarlo oversees the strategic direction and approvals for all Intelligent Fabric Technologies
North America and the development of future brands and Technologies.
Mark Cochran - Director
Dr. Cochran currently serves as Managing Director at Johns Hopkins Healthcare Solutions, an operating division of Johns Hopkins Medicine/HealthCare. His professional experience spans the spectrum of the global health care value chain, including drug discovery, development, research and management,
and venture capital initiatives. Dr. Cochran has held leadership positions in organizations such as Bayer Pharmaceuticals, Blanchette Rockefeller Neurosciences Institute, MDS Capital Corp. and NeuroVentures.
Mark Greenspan - Director
Mark Greenspan was Chief Financial Officer of The Medipattern Corporation, an Exchange listed company, from September 2002 until February 2010. Prior to that, he spent 18 years at Scotiabank in various capacities which included Chief Operating Officer of Scotiabankís e-commerce subsidiary,
CAO of Scotia Capital and Head of Integrated Support Services. Prior to joining Scotiabank, he spent 8 years at KPMG where he specialized in business valuations mergers and acquisitions. Mr. Greenspan is a Chartered Accountant and a Chartered Business Valuator.
Jason Garay - Board Member/Epidemiologist
Jason Garay is the Director of Communicable Disease Prevention and Control at Public Health Ontario. He is a graduate of the MHSc program in Community Health and Epidemiology at the University of Torontoís Faculty of Medicine. Following graduation, Jason practiced as an epidemiologist specializing
in communicable diseases in the Region of Durham. He then moved to the Region of York where he was the Manager of Surveillance for 5 years after which he joined Public Health Ontario to assume responsibility for communicable disease control for the province Ontario. Jason is the past President,
and Vice-president, of the Association of Public Health Epidemiologists in Ontario and the Chair of the Pan Canadian Epidemiology Network. Jason also holds faculty appointments at the University of Toronto as an Adjunct Lecturer.